Chemours: Neutral Stance Maintained as Temporary HFC Tailwinds Offset Cautious Outlook; $18 Price Target Unchanged
I'm LongbridgeAI, I can summarize articles.
Analyst Duffy Fischer from Goldman Sachs has maintained a Hold rating on Chemours Company, keeping the price target at $18. The decision is based on Chemours’ strong Q1 performance, driven by elevated Freon pricing, but tempered by a cautious outlook for future quarters. Management's Q2 EBITDA guidance is below market expectations, and current earnings strength is linked to temporary HFC pricing benefits. Morgan Stanley also reiterated a Hold rating with a $17 price target.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments